The firm is a U.S.-based venture capital and venture-building investor specializing in Pre-Seed through early Series A companies. The firm combines direct investment with strategic company development and frequently invests alongside other venture capital partners through co-investment structures. The firm supports early-stage companies that meet its investment criteria and helps prepare businesses for subsequent institutional financing. The firm primarily targets opportunities in the United States.
The firm invests in technologies that improve health, safety, and environmental outcomes for current and future generations. The firm is particularly interested in early-stage opportunities that require both capital and hands-on company-building support to translate innovative technologies into commercially viable products. The firm engages with companies as early as the Pre-Seed and pre-revenue stages and supports progression toward Series A readiness, emphasizing product-market fit, revenue planning, and the development of strong foundations for sustainable growth.
From a company and management team perspective, the firm seeks founders with meaningful experience in their respective fields and a willingness to collaborate closely with investors. A fully established management team is not required at the time of investment. The firm provides hands-on support in company formation, corporate structuring, management recruitment, fundraising, product development, commercialization, and strategic planning. The firm also assists with governance, contract negotiations, financial planning, and preparation for subsequent institutional investment rounds.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
